SCHEMBL21783364

SCHEMBL21783364

CC(C)(C)OC(=O)N(Sc1cnc(F)c(Cl)c1)c1cscn1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783447 0.89 SCN8A (0.33) SCN8A
SCHEMBL21783499 0.82 SCN8A (0.32) SCN8A
SCHEMBL19634149 0.81 SCN8A (0.35) SCN8A
SCHEMBL19633980 0.80 SCN8A (0.35) SCN8A
SCHEMBL20256343 0.78 SCN8A (0.38) SCN8A
SCHEMBL20256852 0.78 SCN8A (0.34) SCN8A
SCHEMBL21783363 0.77 SCN8A (0.43) SCN8A
SCHEMBL20256898 0.77 SCN8A (0.35) SCN8A
SCHEMBL19633949 0.75 SCN8A (0.38) SCN8A
SCHEMBL21783506 0.74 SCN8A (0.34) SCN8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047312-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed
WO-2020047323-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed